Invention Grant
- Patent Title: Pyrrolopyridine derivatives and their use as Crth2 antagonists
- Patent Title (中): 吡咯并吡啶衍生物及其用作Crth2拮抗剂
-
Application No.: US11597781Application Date: 2005-06-16
-
Publication No.: US07666878B2Publication Date: 2010-02-23
- Inventor: Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katharine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
- Applicant: Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katharine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Vinit Kathardekar; Mark Milstead
- Priority: GB0413619.8 20040617; GB0507693.0 20050415
- International Application: PCT/EP2005/006493 WO 20050616
- International Announcement: WO2005/123731 WO 20051229
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/4745
Abstract:
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R 4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Public/Granted literature
- US20080114022A1 Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists Public/Granted day:2008-05-15
Information query
